Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification.
Saved in:
| Title: | Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification. |
|---|---|
| Authors: | Stafford F; Cardio Genomics Program at Centenary Institute, The University of Sydney, Locked Bag 6, Newtown, NSW, 2042, Australia., Thomson K; Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Radcliffe Department of Medicine, Division of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Butters A; Cardio Genomics Program at Centenary Institute, The University of Sydney, Locked Bag 6, Newtown, NSW, 2042, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia., Ingles J; Cardio Genomics Program at Centenary Institute, The University of Sydney, Locked Bag 6, Newtown, NSW, 2042, Australia. j.ingles@centenary.org.au.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. j.ingles@centenary.org.au.; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia. j.ingles@centenary.org.au. |
| Source: | Current cardiology reports [Curr Cardiol Rep] 2021 Jan 12; Vol. 23 (2), pp. 9. Date of Electronic Publication: 2021 Jan 12. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Current Science Country of Publication: United States NLM ID: 100888969 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-3170 (Electronic) Linking ISSN: 15233782 NLM ISO Abbreviation: Curr Cardiol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
